Medication Complexity Screening to Improve Therapeutic Outcomes

Abstract

Medication complexity significantly impacts therapeutic outcomes in patients with chronic diseases and polypharmacy. This review synthesizes current evidence on medication complexity screening tools, their clinical application, and the potential to optimize pharmacotherapy. Emphasis is placed on the mechanisms by which complexity influences adherence, risks, and outcomes, and on practical strategies for integrating screening into healthcare workflows. The article highlights recent advances, guideline recommendations, and future directions for research and practice, aiming to provide clinicians with actionable insights to enhance patient safety and therapeutic effectiveness.

Introduction

The increasing prevalence of chronic diseases and aging populations has led to widespread polypharmacy and intricate medication regimens. Medication complexity, encompassing factors such as dosing frequency, formulation, and administration requirements, poses a challenge for both patients and healthcare providers. High regimen complexity is associated with reduced adherence, increased risk of medication errors, adverse drug events, and suboptimal therapeutic outcomes. Understanding and mitigating medication complexity through systematic screening is essential for optimizing care, particularly in vulnerable populations.

Epidemiology / Disease Burden

Globally, polypharmacy affects up to 50% of older adults, with many exposed to five or more regular medications. Studies indicate that medication regimen complexity is prevalent not only in geriatric cohorts but also in patients with multimorbidity, transplant recipients, and those with mental health conditions. The burden of complex regimens contributes to hospital readmissions, increased healthcare utilization, and higher mortality rates. The World Health Organization recognizes medication safety, including regimen simplification, as a key priority within its Global Patient Safety Challenge.

Pathophysiology

Complex medication regimens increase cognitive and logistic demands on patients. Mechanistically, complexity can lead to confusion regarding timing, dosing, and administration, particularly in those with cognitive impairment or limited health literacy. This burden promotes unintentional nonadherence and may result in subtherapeutic or toxic drug concentrations. Additionally, pharmacokinetic and pharmacodynamic interactions are more likely as regimen complexity escalates, compounding the risk of adverse outcomes.

Risk Factors

Key risk factors for experiencing high medication complexity include advanced age, multiple comorbidities, cognitive impairment, low health literacy, and socioeconomic disadvantage. Use of multiple prescribers and lack of coordinated care also contribute. Specific drug classes, such as anticoagulants, antiretrovirals, and immunosuppressants, often require intricate regimens due to monitoring and titration needs, further heightening complexity.

Clinical Features

Patients with complex medication regimens may present with nonadherence, unexplained therapeutic failure, frequent hospitalizations, or adverse drug reactions. Clinicians should be alert to difficulties in medication management, such as confusion over instructions, missed doses, or improper administration techniques. Assessment should include a detailed medication history and review of all prescribed, over-the-counter, and complementary therapies.

Diagnosis

Screening for medication complexity involves structured tools such as the Medication Regimen Complexity Index (MRCI), which quantifies complexity based on dosage forms, dosing frequencies, and additional instructions. Electronic health record (EHR)-based algorithms are increasingly available for automated complexity assessment. Incorporating patient interviews to identify barriers and discrepancies is essential for a comprehensive evaluation.

Treatment & Management

Management centers on regimen simplification, patient education, and multidisciplinary collaboration. Strategies include deprescribing unnecessary medications, consolidating dosing schedules, selecting fixed-dose combinations, and utilizing adherence aids such as pill organizers or reminder systems. Pharmacists play a pivotal role in reviewing regimens and recommending simplification. Ongoing monitoring and reassessment are crucial to sustain improvements in adherence and outcomes.

Recent Advances / Emerging Therapies

Recent advances include the integration of complexity screening tools into EHRs, enabling real-time identification and intervention. Mobile health (mHealth) applications support individualized medication management and promote patient engagement. Artificial intelligence and machine learning approaches are being explored to predict nonadherence and tailor interventions. The development of user-friendly assessment tools enhances feasibility in routine practice.

Guideline Recommendations

Major guidelines, including those from the American Geriatrics Society and the National Institute for Health and Care Excellence (NICE), advocate for regular medication review and complexity assessment, particularly in older adults and those with polypharmacy. Recommendations emphasize shared decision-making, patient-centered care, and interdisciplinary approaches to regimen simplification. Implementation of standardized screening protocols is encouraged to systematically identify and address complexity.

Conclusion

Medication complexity screening is a vital component of contemporary pharmacotherapy, offering substantial potential to improve adherence, reduce adverse events, and optimize therapeutic outcomes. Incorporating validated tools and multidisciplinary strategies into clinical practice enables proactive identification and mitigation of regimen-related risks. Ongoing research and innovation are needed to refine screening methods and integrate them seamlessly into healthcare systems, ultimately enhancing patient safety and quality of care.